The ASX just put every listed company on notice because of a trick called “share ramping” - it’s when companies release a stream of ASX market announcements that sound exciting to lift their share price, but are light on substance.

In its first-ever supervision report, the ASX said it will target companies that repeatedly use announcements to inflate their price. This all matters because investors rely on ASX announcements to make decisions, and not every flashy headline reflects real progress.

The crackdown is designed to restore trust by ensuring market updates inform investors, rather than influence them.

#ASX #stocks #fintok #money #investing

Artificial intelligence is creating some of the world`s fastest-growing and most valuable companies, but many of the biggest opportunities remain private and inaccessible to most investors. AI Private Opportunities Trust (ASX:AIX) is listing on the ASX this Thursday after having raised over $265 million and will be focused on providing Australian investors with exposure to leading private AI companies through a market-first ASX-listed investment vehicle. Pengana Capital Group Executive Director Adam Myers speaks with The Stock Network`s Lel Smits about the growing AI investment opportunity, why investors may be structurally under-exposed to private AI, and how AIX aims to provide access to this rapidly evolving sector.

🤖 The AI opportunity on ASX
🌐 Investing across the AI ecosystem
🚀 The AIX difference

The Calmer Co. (ASX:CCO) secures Coles acceptance for its new Fiji Kava® FZZR™ product, building on its recent strong domestic retail performance, and advances plans to expand into U.S. retail channels.

🥥 Coles accepts Fiji Kava® FZZR™: Coles approves the ranging of Fiji Kava® FZZR™, an innovative kava product that can be consumed as a sparkling drink, direct-to-mouth supplement or chewable format, with distribution expected to commence in October 2026.
🛒 Strong retail footprint and category leadership: Fiji Kava® products are currently ranked No.1 and No.3 in Coles’ national Stress category; The Calmer Co. now has distribution through both Coles and Woolworths, representing approximately 67% of Australia’s grocery retail footprint.
🇺🇸 U.S. expansion gains momentum: The company estimates it holds around 10% of Amazon USA kava sales and has appointed U.S. natural products brokerage VDriven to support expansion into U.S.-based physical retail channels.

“We are extremely pleased to see Coles support the planned launch of this innovative new Fiji Kava® format as part of its latest range review. The FZZR™ technology provides consumers with a highly convenient and enjoyable way to experience kava, while also broadening the accessibility of the category through flavour innovation and portability.” - The Calmer Co. Founder & CEO Zane Yoshida

Far East Gold (ASX:FEG) is entering a pivotal period as it advances the flagship Idenburg Gold Project in Papua Province, Indonesia, while simultaneously responding to an unsolicited takeover offer from Xinye Gold. The company has advanced the Idenburg Gold Project over the past year, growing the resource, and progressing studies and permitting as it moves toward development. At the same time, the Board has unanimously recommended shareholders reject Xinye Gold`s takeover offer, arguing it does not reflect the company`s value or future growth potential. Far East Gold Managing Director & CEO Shane Menere joins Lel Smits from The Stock Network to discuss the company`s development strategy, the rationale behind the Board`s position on the takeover offer, and the key catalysts investors should be watching in the months ahead.

⛏️ Board recommendation to reject the offer
🪓 Far East Gold valuation
⚒️ Key growth catalysts ahead
🤝 Strategic interest validation
🏭 Strategic investor strategy
🚀 The long-term opportunity

Mesoblast (ASX:MSB, Nasdaq:MESO) has entered a new chapter following the launch of Ryoncil®, with quarterly revenues growing and operating cash burn declining. At the same time, Mesoblast is advancing several late-stage programs across inflammatory diseases, chronic low back pain and heart failure, while outlining what it describes as potential "blockbuster opportunities" across its pipeline. For investors the key question is now whether it can translate its scientific platform into sustainable commercial growth and execute on multiple development programs simultaneously. Mesoblast CEO and Managing Director Dr Silviu Itescu joins Lel Smits from The Stock Network to discuss the next phase of growth, upcoming milestones and the timelines investors should be watching.

🚀 Commercial execution beyond the launch
⚕️ Turning pipeline potential into outcomes
🔬 Managing expectations around catalysts

This week, a sell-off started on Wall Street and circled the planet in just 24 hours. First Alphabet Inc. (GOOG), Google`s parent, had its worst day in over a year after two star AI researchers got poached and Space Exploration Technologies Corp (NASDAQ:SPCX) kept sliding despite its strong debut.

Then America went to sleep, and Asia woke up to the fear. South Korea got hit hardest, its market crashed nearly 10% in a day, with chip giants Samsung and SK Hynix both down around 12%. Japan dropped. Then Europe. Then it rolled back to the US. One nervous day in New York became a global chain reaction.

Why is the whole world this fragile? A big reason is concentration. Just seven tech companies now make up almost 30% of the entire S&P 500 and those names, and the chips behind them, are wired into markets everywhere. So when AI stocks get the jitters, it`s not one sector having a bad day. It`s a load-bearing wall of the global market shaking.

#tech #AI #stocks #fintok #money

Vection Technologies (ASX:VR1) secured approximately $2.3 million in new contracts across five sectors. Four of these new contracts were powered by the Company’s Algho AI platform, further strengthening momentum that has seen total new orders reach around $7 million since April 2026.

🤖 AI-driven contracts across five sectors: Vection Technologies secured five new orders spanning healthcare analytics, luxury fashion, public services accessibility, airport passenger assistance and security, with four of the contracts utilising the Company’s Algho AI platform.
✈️ Accessibility platform gains commercial traction: A European airport operator has ordered Vection Technologies’ Accessibility Kiosk and Algho AI Appliance solution, marking the first commercial airport deployment since the platform’s recent launch and building on technology already operating at Bergamo Caravaggio International Airport.
📈 Recurring revenue milestone achieved: Vection Technologies secured its first annual recurring revenue (ARR) contract in the security segment worth approximately $1.3 million ARR, representing a shift from project-based work toward subscription-style revenue streams.

“This round of orders is important not just for the revenue, but for what it demonstrates about the breadth of Vection`s technology portfolio. Four of these contracts are powered by Algho AI, across sectors as different as clinical laboratories and luxury fashion.” - Vection Technologies Managing Director & Executive Chairman Gianmarco Biagi

The price you pay for petrol has almost nothing to do with your local petrol station, it’s set by events on the other side of the world, and this week`s a perfect example. For years, Iran one of the world`s big oil producers, has been mostly banned from selling its oil, thanks to US sanctions but that has just changed.

After talks in Switzerland the US gave Iran a 60-day pass to sell its oil again, but the deal comes with strings attached. Iran has to keep the Strait of Hormuz open and let nuclear inspectors in. If either side walks away, the oil taps could slam shut again.

We`ve already seen how fragile this deal is - over the weekend, Trump threatened to hit Iran again if commitments weren`t met. Enjoy any relief at the pump you get because, as we have seen with this war, the peace might not last.

#oil #iran #fintok #trump #money